Showing results (341-350 of 428) with videos related to
Sort By:
Pageof 43
Muscle & Nerve|July 21, 2022
Thermoneutral Housing and a Western Diet Combination Exacerbates Dysferlin-Deficient Muscular DystrophyGraham S Donen, Zoe White, Elodie Sauge, et al.Blood|April 1, 1991
RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemiaA Biondi, A Rambaldi, M Alcalay, et al.British Journal of Haematology|April 1, 1992
Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapseA Biondi, V Rossi, P F di Celle, et al.British Journal of Haematology|March 1, 1996
Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemiaG Cimino, L Elia, A Rivolta, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
T cell receptor delta gene organization and expression in normal and leukemic natural killer cellsA Biondi, P Allavena, V Rossi, et al.Frontiers in Pharmacology|September 7, 2018
Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityFederica Barbieri, Roberto Würth, Alessandra Pattarozzi, et al.British Journal of Pharmacology|May 26, 2012
Cannabidiol inhibits angiogenesis by multiple mechanismsM Solinas, P Massi, A R Cantelmo, et al.Lancet (London, England)|December 12, 1992
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaF Lo Coco, D Diverio, P P Pandolfi, et al.Leukemia|April 1, 1992
Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapseA Biondi, S Yokota, T E Hansen-Hagge, et al.FEBS Letters|January 30, 1995
Analysis of the N-linked oligosaccharides of human C1s using electrospray ionisation mass spectrometryY Petillot, P Thibault, N M Thielens, et al.Pageof 43